Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06707103 · ClinicalTrials.gov registry record · Phase 3
Tissue Repair Gel in Venous Leg Ulcers in AU/US
A Phase 3 study of Venous Leg Ulcer and Wound Heal, sponsored by TR Therapeutics.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 312
- Enrollment target
- 12
- Study locations
NCT06707103: Recruiting Phase 3 study of Venous Leg Ulcer and Wound Heal, sponsored by TR Therapeutics.
NCT06707103 is a Phase 3 study of Venous Leg Ulcer and Wound Heal that is actively recruiting participants, run by TR Therapeutics. The registered enrollment target is 312 participants, above the 236-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (32% higher). The trial reports 12 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06707103, a Phase 3 study of Venous Leg Ulcer and Wound Heal, is actively recruiting participants, sponsored by TR Therapeutics.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 312 participants
- Enrollment target
- 12
- Study locations
Study Summary
The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
Primary Outcome
Patient count
Conditions Studied
Interventions
- OTHER Standard of care
- DRUG TR987 0.1% gel + Standard of Care
Study Locations (12)
New South Wales
- Clincial Research Site 62 - Camperdown
- Clinical Research Site 84 - Kogarah
- Clincial Research Site 78 - Orange
- Clincial Research Site 85 - Sydney
Victoria
- Clincial Research Site 74 - Bendigo
- Clincial Research Site 60 - Ivanhoe
- Clincial Research Site 65 - Shepparton
Florida
- Clincial Research Site 92 - Jacksonville
Michigan
- Clincial Research Site 77 - Clinton Twp
New York
- Clincial Research Site 82 - Lake Success
Texas
- Clinical Research Site 76 - Fort Worth
Western Australia
- Clincial Research Site 75 - Nedlands
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2025-04 |
| Est. Completion | 2027-02 |
| Phase | Phase 3 |
What NCT06707103 shows while recruiting
NCT06707103 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, above the 236-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (32% higher).
The record links to 8 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT06707103 lists 12 locations in 7 states (New South Wales, Victoria, Florida).
Frequently Asked Questions
What is clinical trial NCT06707103 about?
NCT06707103 is a clinical study titled "Tissue Repair Gel in Venous Leg Ulcers in AU/US". The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
What is the current status of trial NCT06707103?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 312 participants. The study started on 2025-04. Estimated completion is 2027-02.
What conditions does trial NCT06707103 study?
This clinical trial studies the following conditions: Venous Leg Ulcer, Wound Heal, Venous Ulcer, Wound, Venous Stasis.
What interventions are being tested in trial NCT06707103?
The interventions under investigation include: Standard of care (OTHER), TR987 0.1% gel + Standard of Care (DRUG).
Who is sponsoring clinical trial NCT06707103?
This trial is sponsored by TR Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06707103 being conducted?
This trial has 12 study locations across Florida, Michigan, New York, Texas, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06707103's enrollment target sits among peer trials
312 7th of 35 higher than 28 of 35 other Venous Leg Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Leg Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tissue Repair Gel in Venous Leg Ulcers (US)
RECRUITING · Phase 3
-
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)
ACTIVE NOT RECRUITING · Phase 3
-
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
COMPLETED · Phase 3
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia